FDA — authorised 7 June 1995
- Application: NDA020478
- Marketing authorisation holder: ABBVIE
- Local brand name: ULTANE
- Indication: LIQUID — INHALATION
- Status: approved
FDA authorised Sevoflurane Inhalational Induction and Maintenance on 7 June 1995
Yes. FDA authorised it on 7 June 1995.
ABBVIE holds the US marketing authorisation.